vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and Gaming & Leisure Properties, Inc. (GLPI). Click either name above to swap in a different company.
Gaming & Leisure Properties, Inc. is the larger business by last-quarter revenue ($420.0M vs $284.0M, roughly 1.5× ACADIA PHARMACEUTICALS INC). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs 57.0%, a 39.3% gap on every dollar of revenue. On growth, ACADIA PHARMACEUTICALS INC posted the faster year-over-year revenue change (9.4% vs 6.3%). Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (17.5% CAGR vs 5.0%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
Gaming and Leisure Properties, Inc. is a real estate investment trust (REIT) specializing in casino properties, based in Wyomissing, Pennsylvania. It was formed in November 2013 as a corporate spin-off from Penn National Gaming. The company owns 62 casino properties, all of which are leased to other companies.
ACAD vs GLPI — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $284.0M | $420.0M |
| Net Profit | $273.6M | $239.4M |
| Gross Margin | 90.8% | — |
| Operating Margin | 6.1% | 79.4% |
| Net Margin | 96.3% | 57.0% |
| Revenue YoY | 9.4% | 6.3% |
| Net Profit YoY | 90.3% | 40.5% |
| EPS (diluted) | $1.61 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $420.0M | ||
| Q4 25 | $284.0M | $407.0M | ||
| Q3 25 | $278.6M | $397.6M | ||
| Q2 25 | $264.6M | $394.9M | ||
| Q1 25 | $244.3M | $395.2M | ||
| Q4 24 | $259.6M | $389.6M | ||
| Q3 24 | $250.4M | $385.3M | ||
| Q2 24 | $242.0M | $380.6M |
| Q1 26 | — | $239.4M | ||
| Q4 25 | $273.6M | $275.4M | ||
| Q3 25 | $71.8M | $241.2M | ||
| Q2 25 | $26.7M | $151.4M | ||
| Q1 25 | $19.0M | $165.2M | ||
| Q4 24 | $143.7M | $223.6M | ||
| Q3 24 | $32.8M | $184.7M | ||
| Q2 24 | $33.4M | $208.3M |
| Q1 26 | — | — | ||
| Q4 25 | 90.8% | — | ||
| Q3 25 | 92.2% | — | ||
| Q2 25 | 92.2% | — | ||
| Q1 25 | 91.7% | — | ||
| Q4 24 | 91.6% | — | ||
| Q3 24 | 92.5% | — | ||
| Q2 24 | 92.5% | — |
| Q1 26 | — | 79.4% | ||
| Q4 25 | 6.1% | 89.3% | ||
| Q3 25 | 12.8% | 84.8% | ||
| Q2 25 | 12.2% | 61.3% | ||
| Q1 25 | 7.9% | 65.5% | ||
| Q4 24 | 59.1% | 79.1% | ||
| Q3 24 | 12.6% | 70.4% | ||
| Q2 24 | 12.6% | 77.1% |
| Q1 26 | — | 57.0% | ||
| Q4 25 | 96.3% | 67.6% | ||
| Q3 25 | 25.8% | 60.7% | ||
| Q2 25 | 10.1% | 38.4% | ||
| Q1 25 | 7.8% | 41.8% | ||
| Q4 24 | 55.4% | 57.4% | ||
| Q3 24 | 13.1% | 47.9% | ||
| Q2 24 | 13.8% | 54.7% |
| Q1 26 | — | — | ||
| Q4 25 | $1.61 | $0.96 | ||
| Q3 25 | $0.42 | $0.85 | ||
| Q2 25 | $0.16 | $0.54 | ||
| Q1 25 | $0.11 | $0.60 | ||
| Q4 24 | $0.86 | $0.79 | ||
| Q3 24 | $0.20 | $0.67 | ||
| Q2 24 | $0.20 | $0.77 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.7M | $274.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.2B | $5.0B |
| Total Assets | $1.6B | $13.8B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $274.5M | ||
| Q4 25 | $177.7M | — | ||
| Q3 25 | $258.0M | — | ||
| Q2 25 | $253.6M | — | ||
| Q1 25 | $217.7M | — | ||
| Q4 24 | $319.6M | $560.8M | ||
| Q3 24 | $155.1M | $560.8M | ||
| Q2 24 | $177.1M | $560.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | $7.2B | ||
| Q3 25 | — | $7.2B | ||
| Q2 25 | — | $6.9B | ||
| Q1 25 | — | $6.9B | ||
| Q4 24 | — | $7.7B | ||
| Q3 24 | — | $7.4B | ||
| Q2 24 | — | $6.6B |
| Q1 26 | — | $5.0B | ||
| Q4 25 | $1.2B | $4.6B | ||
| Q3 25 | $917.3M | $4.6B | ||
| Q2 25 | $822.4M | $4.6B | ||
| Q1 25 | $765.2M | $4.2B | ||
| Q4 24 | $732.8M | $4.3B | ||
| Q3 24 | $577.2M | $4.3B | ||
| Q2 24 | $516.7M | $4.1B |
| Q1 26 | — | $13.8B | ||
| Q4 25 | $1.6B | $12.9B | ||
| Q3 25 | $1.3B | $12.8B | ||
| Q2 25 | $1.2B | $12.5B | ||
| Q1 25 | $1.1B | $12.1B | ||
| Q4 24 | $1.2B | $13.1B | ||
| Q3 24 | $976.9M | $12.7B | ||
| Q2 24 | $914.1M | $11.8B |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.56× | ||
| Q3 25 | — | 1.57× | ||
| Q2 25 | — | 1.51× | ||
| Q1 25 | — | 1.63× | ||
| Q4 24 | — | 1.81× | ||
| Q3 24 | — | 1.74× | ||
| Q2 24 | — | 1.60× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.7M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | -0.18× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-48.7M | $1.1B | ||
| Q3 25 | $74.3M | $240.3M | ||
| Q2 25 | $64.0M | $293.4M | ||
| Q1 25 | $20.3M | $252.5M | ||
| Q4 24 | $40.4M | $1.1B | ||
| Q3 24 | $63.2M | $270.4M | ||
| Q2 24 | $25.0M | $252.1M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $73.9M | $183.0M | ||
| Q2 25 | — | $272.3M | ||
| Q1 25 | — | $239.6M | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | $63.2M | $261.5M | ||
| Q2 24 | — | $245.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 26.5% | 46.0% | ||
| Q2 25 | — | 69.0% | ||
| Q1 25 | — | 60.6% | ||
| Q4 24 | — | 275.3% | ||
| Q3 24 | 25.2% | 67.9% | ||
| Q2 24 | — | 64.4% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 0.1% | 14.4% | ||
| Q2 25 | — | 5.3% | ||
| Q1 25 | — | 3.3% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | 0.0% | 2.3% | ||
| Q2 24 | — | 1.9% |
| Q1 26 | — | — | ||
| Q4 25 | -0.18× | 4.10× | ||
| Q3 25 | 1.03× | 1.00× | ||
| Q2 25 | 2.40× | 1.94× | ||
| Q1 25 | 1.07× | 1.53× | ||
| Q4 24 | 0.28× | 4.80× | ||
| Q3 24 | 1.93× | 1.46× | ||
| Q2 24 | 0.75× | 1.21× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACAD
| Nuplazid | $174.4M | 61% |
| Daybue | $109.6M | 39% |
GLPI
Segment breakdown not available.
